FDA Seeks Comments on Medication Guide Reporting Rules
Published Date: 7/1/2026
Notice
Summary
The FDA is updating how it collects info about Medication Guides—those important leaflets that come with some prescription drugs to keep patients safe. This affects drug makers who must follow new rules about what info to include and how to share it. Comments on these changes are open until July 31, 2026, and the update aims to keep patients informed without adding extra costs.
Analyzed Economic Effects
5 provisions identified: 0 benefits, 4 costs, 1 mixed.
Drug Sponsors Must Submit Medication Guides
If you are a holder of a new drug application, FDA expects 70 application holders to prepare and submit one Medication Guide annually. FDA estimates each submission takes 320 hours on average, totaling 22,400 hours across all sponsors.
Manufacturers Must Ensure Adequate Guide Supply
Manufacturers who hold relevant applications must ensure distributors and authorized dispensers have an adequate supply or means to produce Medication Guides. FDA estimates 70 manufacturers will make an average of 9,000 disclosures each annually, with an average 1.25 hours per disclosure, totaling 787,500 hours.
Distributors Must Provide Guides to Pharmacies
Distributors that ship drugs requiring Medication Guides must provide the Guide or the means to produce it to authorized dispensers. FDA estimates 191 such distributors will each make 9,000 disclosures annually, with 1.25 hours per disclosure, totaling 2,148,750 hours.
Pharmacies' Dispensing Time Estimated at 10 Seconds
Authorized dispensers (pharmacies) are expected to dispense Medication Guides to patients; FDA estimates 88,736 authorized dispensers will each distribute to 5,705 patients annually, for a total of 506,238,880 dispensings. FDA attributes 10 seconds (0.0027 hours) of burden per dispensing, totaling 1,366,845 hours.
Net Change: Hours Decrease, Responses Increase
FDA states that after adjusting estimates, the information collection reflects a decrease of 22,938,375 hours and an increase of 4,829,782 responses annually related to Medication Guide requirements.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16714, Agency Information Collection Activities; Proposed Collection; Comment Request; Third Party Disclosure and Recordkeeping Requirements for Reportable Food
The Food and Drug Administration (FDA or the Agency) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection provisions of FDA's third-party disclosure and recordkeeping requirements for reportable food.
2026-16712, Agency Information Collection Activities; Proposed Collection; Comment Request; Imports and Electronic Import Entries
The FDA wants your thoughts on how they collect info about imports and electronic import entries. If you’re involved in importing goods, this could affect you! They’re asking for comments by October 16, 2026, to help improve the process without adding extra costs or hassle.
2026-16715, Agency Information Collection Activities; Proposed Collection; Comment Request; Investigational New Drug Application Requirements
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Previous / Next Documents
Previous: 2026-13345, Steel Concrete Reinforcing Bar From the Republic of T[uuml]rkiye: Final Results of Countervailing Duty Administrative Review; 2023
The U.S. Department of Commerce found that steel concrete reinforcing bars (rebar) from Türkiye received unfair government help during 2023. Because of this, extra duties (taxes) will apply starting July 1, 2026, affecting importers and sellers of this rebar. This move aims to keep the playing field fair for U.S. businesses and could impact prices and trade.
Next: 2026-13312, Notice of Inventory Completion: University of Rhode Island, Kingston, RI
The University of Rhode Island has finished checking its collection of Native American human remains and found they belong to at least 31 individuals connected to local tribes. Starting August 3, 2026, these remains can be returned to the tribes for proper care. This important step respects Native American heritage and follows federal law, with no costs mentioned.